Enanta Pharmaceuticals, Inc.ENTANASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank43
3Y CAGR-9.8%
5Y CAGR-18.0%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-9.8%/yr
vs -8.9%/yr prior
5Y CAGR
-18.0%/yr
Recent acceleration
Acceleration
-0.9pp
Decelerating
Percentile
P43
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $32.30M | -13.3% |
| 2024 | $37.23M | -56.4% |
| 2023 | $85.39M | +94.1% |
| 2022 | $43.99M | -23.1% |
| 2021 | $57.21M | -34.3% |
| 2020 | $87.13M | +70.1% |
| 2019 | $51.23M | -19.8% |
| 2018 | $63.90M | -2.7% |
| 2017 | $65.67M | +296.2% |
| 2016 | $16.58M | - |